Heart failure drug shows promise for vessel health
NCT ID NCT05420012
First seen Oct 31, 2025 · Last updated May 25, 2026 · Updated 25 times
Summary
This study looked at whether the drug vericiguat can improve blood vessel function, reduce inflammation, and make people with heart failure feel better. 26 adults with heart failure with reduced ejection fraction took vericiguat alongside their standard treatments. Researchers measured changes in blood vessel dilation, walking distance, and symptom scores to see if the drug offers extra benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Utah Hospital
Salt Lake City, Utah, 84132, United States
-
Veterans Affairs Salt Lake City Health Care System (VAMC)
Salt Lake City, Utah, 84148, United States
Conditions
Explore the condition pages connected to this study.